Variant report
Variant | nsv555940 |
---|---|
Chromosome Location | chr11:93026912-93028940 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs117364256 | chr11:93026921-93026922 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs190250907 | chr11:93026941-93026942 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs372570916 | chr11:93026973-93026974 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs111301679 | chr11:93027003-93027004 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs538153168 | chr11:93027017-93027018 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs546596880 | chr11:93027096-93027097 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs117123345 | chr11:93027130-93027131 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs574910330 | chr11:93027154-93027155 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs137887075 | chr11:93027218-93027219 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs12421676 | chr11:93027220-93027221 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs370520779 | chr11:93027371-93027372 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs546125866 | chr11:93027378-93027379 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs74654244 | chr11:93027418-93027419 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs566501845 | chr11:93027429-93027430 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs79426814 | chr11:93027431-93027432 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs186609262 | chr11:93027455-93027456 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs79110101 | chr11:93027458-93027459 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs562016532 | chr11:93027496-93027497 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs529675683 | chr11:93027556-93027557 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs547774461 | chr11:93027568-93027569 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs190233738 | chr11:93027582-93027583 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs180755941 | chr11:93027594-93027595 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs533417067 | chr11:93027595-93027596 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs79791663 | chr11:93027607-93027608 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs34898429 | chr11:93027712-93027713 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs75541417 | chr11:93027716-93027717 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs148559936 | chr11:93027809-93027810 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs532010085 | chr11:93027826-93027827 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs11020246 | chr11:93027844-93027845 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs113262070 | chr11:93027870-93027871 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs538481830 | chr11:93027912-93027913 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs142917984 | chr11:93027942-93027943 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs146121181 | chr11:93027945-93027946 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs185240125 | chr11:93027969-93027970 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs546287508 | chr11:93027990-93027991 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs113532024 | chr11:93028023-93028024 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs557935413 | chr11:93028059-93028060 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs190740329 | chr11:93028065-93028066 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs543595408 | chr11:93028134-93028135 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs565795959 | chr11:93028201-93028202 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs10831021 | chr11:93028219-93028220 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs578252951 | chr11:93028291-93028292 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs184071420 | chr11:93028351-93028352 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs368642046 | chr11:93028373-93028374 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs571620251 | chr11:93028400-93028401 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs547997316 | chr11:93028433-93028434 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs576097896 | chr11:93028437-93028438 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs58412721 | chr11:93028438-93028439 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs11824203 | chr11:93028512-93028513 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs112078654 | chr11:93028513-93028514 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Cervical cancer | 21062161 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 22429812 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Developmental delay | 21147756 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21958427 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Mental retardation | 21062444 | CNVD |
Cancer | 21499728 | CNVD |
Breast cancer | 19181860 | CNVD |
Breast cancer | 17603634 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Basal cell lymphoma | 16790693 | CNVD |
Breast cancer | 21509527 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:93019400-93028600 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
2 | chr11:93023200-93028600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr11:93026200-93028400 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr11:93028200-93028800 | Enhancers | Fetal Brain Male | brain |
5 | chr11:93028400-93029000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
6 | chr11:93028600-93028800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
7 | chr11:93028600-93029000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
8 | chr11:93028600-93029000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
9 | chr11:93028600-93029200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
10 | chr11:93028600-93029200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
11 | chr11:93028600-93029400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
12 | chr11:93028600-93029400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
13 | chr11:93028600-93029600 | Enhancers | Pancreatic Islets | Pancreatic Islet |
14 | chr11:93028800-93029000 | Bivalent Enhancer | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
15 | chr11:93028800-93029200 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |